Jerome Barakos

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Juha O. Rinne, David J. Brooks, Martin N. Rossor et al. · The Lancet Neurology · 2010 · 695 citations

Life Sciences, Neurology, Neuroscience +17

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

Stephen Salloway, Spyros Chalkias, Frederik Barkhof et al. · JAMA Neurology · 2021 · 584 citations · Full text

Medicine, Neurology, Pharmacology +16

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

Reisa A. Sperling, Stephen Salloway, David J. Brooks et al. · The Lancet Neurology · 2012 · 510 citations

Medicine, Neurology, Neuroscience +12

Novel symptomatology and changing epidemiology of domoic acid toxicosis in California sea lions ( <i>Zalophus californianus</i> ): an increasing risk to marine mammal health

Tracey Goldstein, Jonna A. K. Mazet, Tanja S. Zabka et al. · Proceedings of the Royal Society B Biological Sciences · 2007 · 206 citations · Full text

Pharmacy, Marine Sciences, Toxicology +17

Orbit, skull base, and pharynx: contrast-enhanced fat suppression MR imaging.

Jerome Barakos, W P Dillon, W Chew · Radiology · 1991 · 134 citations

Medicine, Radiology, Biomedical Imaging +16